ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

MYNZ Mainz BioMed NV

0.83
-0.0268 (-3.13%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Mainz BioMed NV MYNZ NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.0268 -3.13% 0.83 18:57:21
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.8655 0.78 0.8794 0.8181 0.8568
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
25/4/202408:29GLOBEMainz Biomed Reports Positive Topline Results from Pooled..
09/4/202407:01GLOBEMainz Biomed Reports Full Year 2023 Financial Results
19/3/202407:01GLOBEMainz Biomed Organizes HALLO DOC! Event to Highlight..
18/3/202407:01GLOBEMainz Biomed: Webinar on Early Detection of Colorectal..
12/3/202407:01GLOBEMainz Biomed Presents ColoAlert® at UDH Congress 2024:..
05/3/202407:01GLOBEMainz Biomed Partners with Trusted Health Advisors to..
27/2/202407:01GLOBEMainz Biomed to Showcase at the Gynecology Conference in..
22/2/202407:01GLOBEMainz Biomed Announces Distribution Partnership with..
21/2/202407:01GLOBEMainz Biomed Establishes Strategic Partnership with TomaLab..
06/2/202407:01GLOBEMainz Biomed Establishes Physician-Led Laboratory Expanding..
11/1/202407:01GLOBEMainz Biomed and TestDNA Drive CRC Innovation at the 10th..
09/1/202407:01GLOBEMainz Biomed Provides Year-End Corporate Review 2023
19/12/202307:01GLOBEMainz Biomed and Bantleon Partner to Elevate Corporate..
12/12/202307:01GLOBEMainz Biomed Showcases ColoAlert® at Two Prominent..
05/12/202308:01GLOBEMainz Biomed Reports Positive Topline Results from U.S...
29/11/202307:01GLOBEMainz Biomed’s Presentation at the 35th Annual Piper Sandler..
20/11/202307:01GLOBEMainz Biomed to Present at the 35th Annual Piper Sandler..
16/11/202307:01GLOBEMainz Biomed Reports Third Quarter 2023 Financial Results..
15/11/202308:01GLOBEMainz Biomed Announces Closing of $5.0 million Registered..
13/11/202308:00GLOBEMainz Biomed Announces Pricing of $5.0 million Registered..
09/11/202307:01GLOBEMainz Biomed Partners with Liquid Biosciences to Harness the..
07/11/202307:01GLOBEMainz Biomed to Showcase ColoAlert® at Leading Global..
31/10/202307:01GLOBEMainz Biomed Reports Success from Employee Colorectal Cancer..
26/10/202307:01GLOBEMainz Biomed Appoints Tarrin Khairi-Taraki as VP of..
18/10/202307:01GLOBEMainz Biomed Presents Groundbreaking Results of ColoFuture..
11/10/202307:01GLOBEMainz Biomed to Showcase ColoAlert® at UEG Week 2023 in..
05/10/202307:01GLOBEMainz Biomed to Attend the JonesTrading 2023 Healthcare..
04/10/202307:01GLOBEMainz Biomed Announces Live Launch of ColoAlert® with..
27/9/202307:01GLOBEMainz Biomed to Present Detailed Results of ColoFuture Study..
20/9/202302:01GLOBEMainz Biomed to Present at the Cantor Fitzgerald Global..
13/9/202302:01GLOBEMainz Biomed’s ColoFuture Study, Evaluating its Novel mRNA..
05/9/202302:01GLOBEMainz Biomed Announces Strategic Partnership with Ärztliches..
29/8/202302:01GLOBEMainz Biomed to Present at the H.C. Wainwright Global..
22/8/202302:01GLOBEMainz Biomed Announces Live Launch of ColoAlert® with..
15/8/202305:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/8/202302:01GLOBEMainz Biomed Announces Financial Half Year Results 2023 and..
01/8/202302:01GLOBEMainz Biomed Announces Live Launch of ColoAlert® with..
18/7/202302:01GLOBEMainz Biomed Announces Collaboration with Fugene Genetics in..
11/7/202315:35EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/7/202315:15EDGAR2Form D - Notice of Exempt Offering of Securities
29/6/202302:01GLOBEMainz Biomed Secures up to $50M in New Funding
28/6/202315:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/6/202315:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/6/202302:01GLOBEMainz Biomed to Attend ESMO World Congress on..
20/6/202302:01GLOBEMainz Biomed Expands into Romania Through Partnership with..
31/5/202302:01GLOBEMainz Biomed Expands Commercial Footprint into Poland
24/5/202302:01GLOBEMainz Biomed Processes First Patients from Colorectal Cancer..
16/5/202302:01GLOBEMainz Biomed Announces First Quarter 2023 Financial Results..
10/5/202302:01GLOBEMainz Biomed Partners with Microba Life Sciences for the..
03/5/202302:01GLOBEMainz Biomed Announces Addition of Eurofins GeLaMed to its..

Su Consulta Reciente

Delayed Upgrade Clock